Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Rafael Luboshitzky, Zilla Shen-Orr, Orna Tzischichinsky, Marina Maldonado, Paula Herer & Peretz Lavie. (2001) ACTIGRAPHIC SLEEP-WAKE PATTERNS AND URINARY 6-SULFATOXYMELATONIN EXCRETION IN PATIENTS WITH ALZHEIMER'S DISEASE. Chronobiology International 18:3, pages 513-524.
Read now
Read now
Eus J. W. Van Someren. (2000) CIRCADIAN RHYTHMS AND SLEEP IN HUMAN AGING. Chronobiology International 17:3, pages 233-243.
Read now
Read now
Articles from other publishers (72)
Sonali Sundram, Rishabha Malviya & Rajendra Awasthi. (2023) Genetic Causes of Alzheimer’s Disease and the Neuroprotective Role of
Melatonin in its Management. CNS & Neurological Disorders - Drug Targets 22:9, pages 1302-1312.
Crossref
Crossref
Faizan Ahmad, Punya Sachdeva, Jasmine Sarkar & Raafiah Izhaar. (2022) Circadian dysfunction and Alzheimer's disease – An updated review. AGING MEDICINE 6:1, pages 71-81.
Crossref
Crossref
Zhenwei Zhai, Danni Xie, Tao Qin, Yanmei Zhong, Ying Xu & Tao Sun. (2022) Effect and Mechanism of Exogenous Melatonin on Cognitive Deficits in Animal Models of Alzheimer’s Disease: A Systematic Review and Meta-analysis. Neuroscience 505, pages 91-110.
Crossref
Crossref
Araceli Abad, Cristina Matesanz, Carmen Acosta & Cristina López. 2022. Pathy's Principles and Practice of Geriatric Medicine. Pathy's Principles and Practice of Geriatric Medicine
570
580
.
Nancy A. Hodgson, Nalaka Gooneratne, Adriana Perez, Sonia Talwar & Liming Huang. (2021) A timed activity protocol to address sleep-wake disorders in home dwelling persons living with dementia: the healthy patterns clinical trial. BMC Geriatrics 21:1.
Crossref
Crossref
M.F. Vecchierini, U. Kilic-Huck & M.A. Quera-Salva. (2021) La mélatonine (MEL) et son utilisation dans les pathologies neurologiques et l’insomnie : recommandations de la Société française de recherche et de médecine du sommeil (SFRMS). Médecine du Sommeil 18:2, pages 70-89.
Crossref
Crossref
M.F. Vecchierini, U. Kilic-Huck & M.A. Quera-Salva. (2021) Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS). Revue Neurologique 177:3, pages 245-259.
Crossref
Crossref
Zanna J. Voysey, Roger A. Barker & Alpar S. Lazar. (2020) The Treatment of Sleep Dysfunction in Neurodegenerative Disorders. Neurotherapeutics 18:1, pages 202-216.
Crossref
Crossref
Rokeya Akter, Deepak Kaushik, Kuldeep Kumar & Md. Habibur Rahman. 2021. Autism Spectrum Disorder and Alzheimer's Disease. Autism Spectrum Disorder and Alzheimer's Disease
1
19
.
Jenny McCleery & Ann L Sharpley. (2020) Pharmacotherapies for sleep disturbances in dementia. Cochrane Database of Systematic Reviews 2020:11.
Crossref
Crossref
Dongmei Chen, Tao Zhang & Tae Ho Lee. (2020) Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases. Biomolecules 10:8, pages 1158.
Crossref
Crossref
Yu Chen Chang & Jin Young Kim. (2019) Therapeutic implications of circadian clocks in neurodegenerative diseases. Journal of Neuroscience Research 98:6, pages 1095-1113.
Crossref
Crossref
Aliza K. De Nobrega, Kristine V. Luz & Lisa C. Lyons. 2020. Reviews on New Drug Targets in Age-Related Disorders. Reviews on New Drug Targets in Age-Related Disorders
193
265
.
Monika Jürgenson, Tamara Zharkovskaja, Aveli Noortoots, Margarita Morozova, Allan Beniashvili, Max Zapolski & Alexander Zharkovsky. (2019) Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid-predominant mouse model of Alzheimer's disease. Journal of Pharmacy and Pharmacology 71:11, pages 1695-1705.
Crossref
Crossref
Daniel P. Cardinali. (2019) Melatonin: Clinical Perspectives in Neurodegeneration. Frontiers in Endocrinology 10.
Crossref
Crossref
Karine Scheuermaier, Mirjam Münch, Joseph M. Ronda & Jeanne F. Duffy. (2018) Improved cognitive morning performance in healthy older adults following blue-enriched light exposure on the previous evening. Behavioural Brain Research 348, pages 267-275.
Crossref
Crossref
Yunkyung Hong, Hyunsoo Kim, Seunghoon Lee, Yunho Jin, Jeonghyun Choi, Sang-Rae Lee, Kyu-Tae Chang & Yonggeun Hong. (2017) Role of melatonin combined with exercise as a switch-like regulator for circadian behavior in advanced osteoarthritic knee. Oncotarget 8:57, pages 97633-97647.
Crossref
Crossref
Hirotaka Sekiguchi, Shuji Iritani & Kiyoshi Fujita. (2017) Bright light therapy for sleep disturbance in dementia is most effective for mild to moderate Alzheimer's type dementia: a case series. Psychogeriatrics 17:5, pages 275-281.
Crossref
Crossref
Annette Mehling & Corinne Reymermier. 2017. Agache's Measuring the Skin. Agache's Measuring the Skin
15
22
.
Jenny McCleery, Daniel A. Cohen & Ann L Sharpley. (2016) Pharmacotherapies for sleep disturbances in dementia. Cochrane Database of Systematic Reviews.
Crossref
Crossref
RUIQI FENG, LIJUAN LI, HAIYAN YU, MIN LIU & WEI ZHAO. (2016) Melanopsin retinal ganglion cell loss and circadian dysfunction in Alzheimer's disease (Review). Molecular Medicine Reports 13:4, pages 3397-3400.
Crossref
Crossref
Daniel Pedro CardinaliDaniel Pedro Cardinali. 2016. Ma Vie en Noir. Ma Vie en Noir
215
243
.
Kazuo Mishima. 2016. Circadian Clocks: Role in Health and Disease. Circadian Clocks: Role in Health and Disease
103
115
.
Annette Mehling & Corinne Reymermier. 2016. Measuring the Skin. Measuring the Skin
1
8
.
Nalaka S. Gooneratne & Michael V. Vitiello. (2014) Sleep in Older Adults. Clinics in Geriatric Medicine 30:3, pages 591-627.
Crossref
Crossref
Daniel Cardinali, Daniel Vigo, Natividad Olivar, María Vidal & Luis Brusco. (2014) Melatonin Therapy in Patients with Alzheimer’s Disease. Antioxidants 3:2, pages 245-277.
Crossref
Crossref
Jenny McCleery, Daniel A. Cohen & Ann L Sharpley. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Dorothy Forbes, Catherine M Blake, Emily J Thiessen, Shelley Peacock & Pamela Hawranik. (2014) Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Hideki Tanaka, Norihisa Tamura, Ai Yamamoto & Maki Furutani
. (2014) Sleep and health promotion for the elderly
. Stress Science Research 29:0, pages 10-19.
Crossref
Crossref
Venkataramanujam Srinivasan, Edward C. Lauterbach, Charanjit Kaur, Asma Hayati Ahmad, Mahaneem Mohamed, Atul Prasad & Samuel D. Shillcutt. 2014. Melatonin and Melatonergic Drugs in Clinical Practice. Melatonin and Melatonergic Drugs in Clinical Practice
235
247
.
Antonio Carrillo-Vico, Patricia Lardone, Nuria Álvarez-Sánchez, Ana Rodríguez-Rodríguez & Juan Guerrero. (2013) Melatonin: Buffering the Immune System. International Journal of Molecular Sciences 14:4, pages 8638-8683.
Crossref
Crossref
Seithikurippu R. Pandi-Perumal, Ahmed S. BaHammam, Gregory M. Brown, D. Warren Spence, Vijay K. Bharti, Charanjit Kaur, Rüdiger Hardeland & Daniel P. Cardinali. (2012) Melatonin Antioxidative Defense: Therapeutical Implications for Aging and Neurodegenerative Processes. Neurotoxicity Research 23:3, pages 267-300.
Crossref
Crossref
José María García-Alberca, José Pablo Lara, Belén Cruz, Victoria Garrido, Esther Gris & Miguel Ángel Barbancho. (2013) Sleep Disturbances in Alzheimer’s Disease Are Associated With Neuropsychiatric Symptoms and Antidementia Treatment. Journal of Nervous & Mental Disease 201:3, pages 251-257.
Crossref
Crossref
Anna A. Kondratova & Roman V. Kondratov. (2012) The circadian clock and pathology of the ageing brain. Nature Reviews Neuroscience 13:5, pages 325-335.
Crossref
Crossref
P. Jennum, J. Santamaria Cano, C. Bassetti, P. Clarenbach, B. Högl, J. Mathis, R. Poirrier, K. Sonka, E. Svanborg, L. Dolenc Grosel, D. Kaynak, M. Kruger, A. Papavasiliou & Z. Zahariev. 2011. European Handbook of Neurological Management. European Handbook of Neurological Management
129
143
.
Venkatramanujam Srinivasan, Charanjit Kaur, Seithikurippu Pandi-Perumal, Gregory M. Brown & Daniel P. Cardinali. (2011) Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value. International Journal of Alzheimer's Disease 2011, pages 1-15.
Crossref
Crossref
Sharon L. Naismith, Simon J.G. Lewis & Naomi L. Rogers. 2011. Human Sleep and Cognition Part II - Clinical and Applied Research. Human Sleep and Cognition Part II - Clinical and Applied Research
21
52
.
DIETER KUNZ & RICHARD MAHLBERG. (2010) A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. Journal of Sleep Research 19:4, pages 591-596.
Crossref
Crossref
A. de Jonghe, J. C. Korevaar, B. C. van Munster & S. E. de Rooij. (2010) Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia. Are there implications for delirium? A systematic review. International Journal of Geriatric Psychiatry 25:12, pages 1201-1208.
Crossref
Crossref
Nils Erik Gilhus, Michael P. Barnes & Michael BraininP. Jennum, J. Santamaria Cano, C. Bassetti, P. Clarenbach, B. Högl, J. Mathis, R. Poirrier, K. Sonka, E. Svanborg, L. Dolenc Groselj, D. Kaynak, M. Kruger, A. Papavasiliou & Z. Zahariev. 2010. European Handbook of Neurological Management. European Handbook of Neurological Management
529
543
.
Daniel P. Cardinali & Michal Karasek. 2010. Principles and Practice of Geriatric Sleep Medicine. Principles and Practice of Geriatric Sleep Medicine
97
106
.
Dorothy Forbes, Ivan Culum, Andrea R Lischka, Debra G Morgan, Shelley Peacock, Jennifer Forbes & Sean Forbes. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Arne Fetveit. (2009) Late-life insomnia: A review. Geriatrics & Gerontology International 9:3, pages 220-234.
Crossref
Crossref
Bradley F. Boeve & Adam L. Boxer. 2009. The Behavioral Neurology of Dementia. The Behavioral Neurology of Dementia
213
253
.
Michael J. Jarzynka, Deepshikha K. Passey, David A. Johnson, Nagarjun V. Konduru, Nicholas F. Fitz, Nicholas M. Radio, Mark Rasenick, Susan Benloucif, Melissa A. Melan & Paula A. Witt-Enderby. (2009) Microtubules modulate melatonin receptors involved in phase-shifting circadian activity rhythms: in vitro and in vivo evidence. Journal of Pineal Research 46:2, pages 161-171.
Crossref
Crossref
Venkataramanujan Srinivasan, S. R. Pandi-Perumal, Warren Spence, Daniel P. Cardinali & Marcel G. Smits. 2008. Sleep and Quality of Life in Clinical Medicine. Sleep and Quality of Life in Clinical Medicine
67
77
.
Analía M. Furio, Luis I. Brusco & D. P. Cardinali. (2007) Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study. Journal of Pineal Research 43:4, pages 404-409.
Crossref
Crossref
Ying-Hui Wu & Dick F. Swaab. (2007) Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer’s disease. Sleep Medicine 8:6, pages 623-636.
Crossref
Crossref
A. Altun & B. Ugur-Altun. (2007) Melatonin: therapeutic and clinical utilization. International Journal of Clinical Practice 61:5, pages 835-845.
Crossref
Crossref
Ying-Hui Wu, Jiang-Ning Zhou, Rawien Balesar, Unga Unmehopa, Aimin Bao, Ralf Jockers, Joop Van Heerikhuize & Dick F. Swaab. (2006) Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: Colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone. The Journal of Comparative Neurology 499:6, pages 897-910.
Crossref
Crossref
V Srinivasan, SR Pandi-Perumal, DP Cardinali, B Poeggeler & R Hardeland. (2006) Melatonin in Alzheimer's disease and other neurodegenerative disorders. Behavioral and Brain Functions 2:1.
Crossref
Crossref
S. R. Pandi‐Perumal, V. Srinivasan, G. J. M. Maestroni, D. P. Cardinali, B. Poeggeler & R. Hardeland. (2006) Melatonin. The FEBS Journal 273:13, pages 2813-2838.
Crossref
Crossref
Daniel P. Cardinali, Analía M. Furio, María P. Reyes & Luis I. Brusco. (2006) The Use of Chronobiotics in the Resynchronization of the Sleep–wake Cycle. Cancer Causes & Control 17:4, pages 601-609.
Crossref
Crossref
Daniel P. Cardinali & Seithikurippu R. Pandi-Perumal. 2006. Clinical Pharmacology of Sleep. Clinical Pharmacology of Sleep
197
206
.
Malcolm Lader, Daniel P. Cardinali & S. R. Pandi-PerumalDaniel P. Cardinali, Analía M. Furio, Luis I. Brusco & Cynthia Liberczuk. 2006. Sleep and Sleep Disorders. Sleep and Sleep Disorders
111
120
.
P. Jennum, J. Santamaria, C. Bassetti, P. Clarenbach, B. Högl, I. Arnulf, R. Poirrier, K. Sonka, E. Svanborg, L. D. Grosels, D. Kaynack, M. Kruger, A. Papavasiliou, P. Reading & Z. Zahariev. 2006. European Handbook of Neurological Management. European Handbook of Neurological Management
552
568
.
V Srinivasan, GJM Maestroni, DP Cardinali, AI Esquifino, SR Pandi Perumal & SC Miller. (2005) Melatonin, immune function and aging. Immunity & Ageing 2:1.
Crossref
Crossref
S.R. Pandi-Perumal, N. Zisapel, V. Srinivasan & D.P. Cardinali. (2005) Melatonin and sleep in aging population. Experimental Gerontology 40:12, pages 911-925.
Crossref
Crossref
V. Srinivasan, S. R. Pandi-Perumal, G. J. M. Maestroni, A. I. Esquifino, R. Hardeland & D. P. Cardinali. (2005) Role of melatonin in neurodegenerative diseases. Neurotoxicity Research 7:4, pages 293-318.
Crossref
Crossref
Cathy A. Alessi, Jennifer L. Martin, Adam P. Webber, E. Cynthia Kim, Judith O. Harker & Karen R. Josephson. (2005) Randomized, Controlled Trial of a Nonpharmacological Intervention to Improve Abnormal Sleep/Wake Patterns in Nursing Home Residents. Journal of the American Geriatrics Society 53:5, pages 803-810.
Crossref
Crossref
Yumiko Mishima, Satoshi Hozumi, Tetsuo Shimizu, Yasuo Hishikawa & Kazuo Mishima. (2005) Passive Body Heating Ameliorates Sleep Disturbances in Patients With Vascular Dementia Without Circadian Phase-Shifting. The American Journal of Geriatric Psychiatry 13:5, pages 369-376.
Crossref
Crossref
Richard Mahlberg, Dieter Kunz, Igor Sutej, Klaus-Peter Kühl & Rainer Hellweg. (2004) Melatonin Treatment of Day-Night Rhythm Disturbances and Sundowning in Alzheimer Disease. Journal of Clinical Psychopharmacology 24:4, pages 456-459.
Crossref
Crossref
Velayudhan Mohan KUMAR. (2004) Body temperature and sleep: Are they controlled by the same mechanism?. Sleep and Biological Rhythms 2:2, pages 103-124.
Crossref
Crossref
Dorothy Forbes, Debra G Morgan, Janet Bangma, Shelley Peacock & J Adamson. 1996. The Cochrane Database of Systematic Reviews. The Cochrane Database of Systematic Reviews.
Frank A.J.L. ScheerGert A. Van MontfransEus J.W. van SomerenGideon MairuhuRuud M. Buijs. (2004) Daily Nighttime Melatonin Reduces Blood Pressure in Male Patients With Essential Hypertension. Hypertension 43:2, pages 192-197.
Crossref
Crossref
Kim A. Dawson. (2004) Temporal organization of the brain: Neurocognitive mechanisms and clinical implications. Brain and Cognition 54:1, pages 75-94.
Crossref
Crossref
Susan M McCurry, Laura E Gibbons, Rebecca G Logsdon & Linda Teri. (2004) Anxiety and Nighttime Behavioral Disturbances: Awakenings in Patients with Alzheimer's Disease. Journal of Gerontological Nursing 30:1, pages 12-20.
Crossref
Crossref
Jerome A. YesavageLeah Friedman, Sonia Ancoli-Israel, Donald Bliwise, Clifford Singer, Michael V. Vitiello, Andrew A. Monjan & Barry Lebowitz. (2016) Development of Diagnostic Criteria for Defining Sleep Disturbance in Alzheimer's Disease. Journal of Geriatric Psychiatry and Neurology 16:3, pages 131-139.
Crossref
Crossref
F. A. J. L. Scheer, A. Kalsbeek & R. M. Buijs. (2003) Cardiovascular Control by the Suprachiasmatic Nucleus: Neural and Neuroendocrine Mechanisms in Human and Rat. Biological Chemistry 384:5.
Crossref
Crossref
Timothy H Monk & David K Welsh. (2003) The role of chronobiology in sleep disorders medicine. Sleep Medicine Reviews 7:6, pages 455-473.
Crossref
Crossref
Arne Fetveit & Bjørn Bjorvatn. (2002) Sleep disturbances among nursing home residents. International Journal of Geriatric Psychiatry 17:7, pages 604-609.
Crossref
Crossref
Barbara Phillips & Sonia Ancoli-Israel. (2001) Sleep disorders in the elderly. Sleep Medicine 2:2, pages 99-114.
Crossref
Crossref